Current Hypertension Reports

, Volume 9, Issue 1, pp 45–52

Mineralocorticoid receptor antagonists


  • Hari Krishnan Parthasarathy
    • Hypertension Research Centre, Division of Medicine & Therapeutics, Ninewells Hospital & Medical SchoolUniversity of Dundee

DOI: 10.1007/s11906-007-0009-3

Cite this article as:
Parthasarathy, H.K. & MacDonald, T.M. Current Science Inc (2007) 9: 45. doi:10.1007/s11906-007-0009-3


With an increasingly aging population, the need for effective treatment of cardiovascular diseases (eg, heart failure, hypertension, and ischemic heart disease) cannot be overemphasized. The vital importance of mineralocorticoid receptor antagonists for treating cardiovascular conditions has only been appreciated in the last decade. The re-emergence of mineralocorticoid receptor antagonists has provided clinicians with an important tool towards complete blockade of the reninangiotensin-aldosterone axis.

Copyright information

© Current Medicine Group LLC 2007